HIVE vs TIGR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

HIVE

57.4
AI Score
VS
HIVE Wins

TIGR

46.7
AI Score

Investment Advisor Scores

HIVE

57score
Recommendation
BUY

TIGR

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HIVE TIGR Winner
Forward P/E 62.8931 14.9925 TIGR
PEG Ratio 0 0 Tie
Revenue Growth 73.5% 32.4% HIVE
Earnings Growth -99.9% -33.3% TIGR
Tradestie Score 57.4/100 46.7/100 HIVE
Profit Margin -98.5% 18.4% TIGR
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD HIVE

Relative Price Performance (Last 90 Days)

HIVE 1M: +10.6% · 3M: -20.1% TIGR 1M: +5.5% · 3M: +0.6%

Current Technical Phase

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.8 · Price: $3.03

TIGR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $4.83

Fundamentals Snapshot

Metric HIVE TIGR
Market Cap
Forward P/E -5.9 5.4
Trailing P/E 10.4
Revenue (TTM)
Revenue Growth 0.7% 0.3%
Gross Margin 0.4% 0.9%
Operating Margin -0.6% 0.4%
EPS -1.33 0.47
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.